除了校对之外:POLD1突变作为基因组不稳定性和癌症免疫逃避的动态编排者
Huiqing Chen1, Jiayu Wei1, Qi Tang1
1School of Life Sciences, Jiangsu University, Zhenjiang, China.
Frontiers in immunology
|July 15, 2025
概括
在DNA聚合酶三角子单元POLD1中的突变破坏了DNA修复,导致癌症. 意想不到的是,这些POLD1突变在微卫星稳定的瘤中增强了抗癌免疫力,改善了对免疫治疗的反应.
科学领域:
- 基因组稳定性和癌症生物学
- DNA复制和修复的分子机制
- 癌症免疫疗法和生物标志物
背景情况:
- 由POLD1编码的DNA聚合酶三角酶 (Pol δ) 是通过其校对外核酶域对DNA复制忠实性和修复至关重要的.
- 在POLD1中发生的突变,特别是在外核酶域中,导致基因组不稳定性和超突变的癌症表型.
- 这些突变与聚合酶校对相关的多重症 (PPAP) 有关,并影响癌症的发展.
研究的目的:
- 审查POLD1突变在癌症中的多样性作用,包括瘤发生和免疫治疗.
- 研究POLD1突变对瘤免疫性和对免疫检查点抑制剂 (ICI) 的反应的影响.
- 突出POLD1突变作为潜在的生物标志物用于免疫疗法在先前耐药的癌症类型.
主要方法:
- 文献综述整合了关于POLD1突变的结构,机制和临床数据.
- 分析与POLD1突变相关的突变特征及其对瘤突变负担的影响.
- 评估POLD1突变,微卫星稳定性 (MSS) 和ICI疗效之间的关系.
主要成果:
- POLD1突变破坏了DNA校对,导致基因组不稳定性和癌症.
- 意想不到的是,POLD1突变在微卫星稳定 (MSS) 瘤中增强了免疫性.
- 这些突变增加了瘤突变负担,并产生了独特的突变特征 (例如,SBS10d),使MSS瘤对ICI敏感.
结论:
- 波尔德1突变是癌症进展和基因组不稳定的重要驱动因素.
- POLD1突变代表了免疫治疗反应的新型预测生物标志物,特别是在MSS瘤中.
- 了解POLD1突变的作用重新定义了治疗策略,并扩大了精确瘤学的可能性.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Cancers Originate from Somatic Mutations in a Single Cell
12.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.9K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K


